Image of the month - November
11 / 17 / 2022
11 / 17 / 2022
10 / 27 / 2022
10 / 26 / 2022
10 / 20 / 2022
We very much look forward to attending the @Society for Immunotherapy of Cancer Annual Meeting in Boston from November 8 to 12, and to showcasing our recent research works through our posters. Plan to stop by to talk of them and about your research programs.
Interested in meeting us to learn on our services offerings and how they can support your needs? Reach us for scheduling!
09 / 12 / 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
Journal of Hematology & Oncology, 2022, October 27
Mariella Spalato‑Ceruso, Fanny Bouteiller, Jean‑Philippe Guegan, Maud Toulmonde, Alban Bessede, Michèle Kind, Sophie Cousin, Xavier Buy, Jean Palussiere, François Le Loarer, Berengere Dadone‑Montaudie, Marina Pulido and Antoine Italiano
09 / 08 / 2022
Save the date for our new in vivo shuttle campaign!
We are committed to providing world-class supports to advance your preclinical projects and immunotherapy drug discovery using syngeneic tumor mouse models through our comprehensive in vivo Immuno-Oncology platform.
Sign up! It’s for early November
07 / 12 / 2022
07 / 07 / 2022